Trevi Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
TRVI Nasdaq 2830 www.trevitherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Trevi Therapeutics, Inc.

Do Trevi Therapeutics’ (TRVI) CORAL Data and GSK’s Exit Reframe Its Chronic Cough Ambitions? - Oct 13th, 2026 4:14 pm
Trevi Therapeutics Announces Oral Presentation Accepted at the CHEST 2026 Annual Meeting - Oct 13th, 2026 5:30 am
Top 4 Healthcare Stocks Backed by Raymond James Analysts - Oct 8th, 2026 8:09 am
Trevi Therapeutics (TRVI) Stock Trades At A Premium To Fair Value - Sep 5th, 2026 11:05 am
Trevi Therapeutics to Participate in Upcoming September Conferences - Sep 3rd, 2026 5:30 am
Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026 - Aug 26th, 2026 5:30 am
Trevi Therapeutics Q2 Earnings Call Highlights - Aug 7th, 2026 12:04 pm
Trevi Therapeutics Inc (TRVI) (Q2 2026) Earnings Call Highlights: Advancing Phase 3 Pipeline ... - Aug 6th, 2026 11:08 pm
Trevi Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates - Aug 6th, 2026 2:05 pm
Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026 - Jul 30th, 2026 2:05 pm
Trevi Therapeutics (TRVI) Soars as Haduvio Taps Into $15B Addressable Market - Jul 17th, 2026 8:20 pm
Trevi Therapeutics Announces Upcoming June and July Event Schedule - Jun 17th, 2026 5:30 am
Trevi Therapeutics Is Up 100%, Pivotal bioVenture Adds Anyway. Here's Why That Matters. - Jun 3rd, 2026 8:04 am
Trevi Therapeutics Maps Haduvio Chronic Cough Push, Sees Cash Runway Into 2030 - May 9th, 2026 3:05 am
Trevi Therapeutics, Inc. Q1 2026 Earnings Call Summary - May 6th, 2026 10:58 am
Why Trevi Therapeutics (TRVI) Is Up 5.9% After Extending Its Cash Runway Into 2030 - May 6th, 2026 10:14 am
Trevi Therapeutics Q1 Earnings Call Highlights - May 5th, 2026 10:08 pm
Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates - May 5th, 2026 2:05 pm